Similarly, in a 2023 study mentioned above, Pan et al. demonstrated that IGFL2-AS1, despite its intracellular function previously mentioned in this review, can also be encapsulated into EVs through hnRNPC, thereby facilitating the transfer of sunitinib resistance between RCC cells[45]. Here, IGFL2 is linked to renal cell carcinoma.